NO20012986L - Kontrollert frigivende formulering av natrium divalproex - Google Patents
Kontrollert frigivende formulering av natrium divalproexInfo
- Publication number
- NO20012986L NO20012986L NO20012986A NO20012986A NO20012986L NO 20012986 L NO20012986 L NO 20012986L NO 20012986 A NO20012986 A NO 20012986A NO 20012986 A NO20012986 A NO 20012986A NO 20012986 L NO20012986 L NO 20012986L
- Authority
- NO
- Norway
- Prior art keywords
- controlled release
- release formulation
- divalproex
- sodium divalproex
- sodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/216,650 US6419953B1 (en) | 1998-12-18 | 1998-12-18 | Controlled release formulation of divalproex sodium |
US12155799P | 1999-02-25 | 1999-02-25 | |
PCT/US1999/029204 WO2000037055A1 (en) | 1998-12-18 | 1999-12-09 | Controlled release formulation of divalproex sodium |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20012986D0 NO20012986D0 (no) | 2001-06-15 |
NO20012986L true NO20012986L (no) | 2001-08-15 |
Family
ID=26819594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20012986A NO20012986L (no) | 1998-12-18 | 2001-06-15 | Kontrollert frigivende formulering av natrium divalproex |
Country Status (25)
Country | Link |
---|---|
EP (1) | EP1140034B1 (es) |
JP (1) | JP2003513882A (es) |
KR (1) | KR20010101295A (es) |
CN (1) | CN1335769A (es) |
AR (1) | AR021443A1 (es) |
AT (1) | ATE254907T1 (es) |
AU (1) | AU2478900A (es) |
BG (1) | BG105665A (es) |
BR (1) | BR9916361A (es) |
CA (1) | CA2330480C (es) |
CO (1) | CO5160287A1 (es) |
CZ (1) | CZ20012201A3 (es) |
DE (1) | DE69913197T2 (es) |
DK (1) | DK1140034T3 (es) |
ES (1) | ES2212667T3 (es) |
HK (1) | HK1043043B (es) |
HU (1) | HUP0105463A3 (es) |
IL (1) | IL143407A0 (es) |
NO (1) | NO20012986L (es) |
PL (1) | PL356899A1 (es) |
PT (1) | PT1140034E (es) |
SI (1) | SI20624A (es) |
SK (1) | SK8252001A3 (es) |
TW (1) | TW585788B (es) |
WO (1) | WO2000037055A1 (es) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6713086B2 (en) | 1998-12-18 | 2004-03-30 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6419953B1 (en) | 1998-12-18 | 2002-07-16 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6511678B2 (en) | 1998-12-18 | 2003-01-28 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US20020025341A1 (en) * | 1998-12-18 | 2002-02-28 | Yihong Qiu | Controlled release formulation of divalproex sodium |
US6528090B2 (en) | 1998-12-18 | 2003-03-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
WO2002051402A1 (en) * | 2000-12-22 | 2002-07-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
MXPA03010705A (es) * | 2001-05-25 | 2004-05-27 | Cephalon Inc | Formulaciones farmaceuticas solidas que comprenden modafinil. |
US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
US20040005357A1 (en) * | 2002-07-03 | 2004-01-08 | Sherman Bernard Charles | Extended-release tablets comprising divalproex sodium |
US20040048931A1 (en) | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
BRPI0408323A (pt) * | 2003-03-14 | 2006-03-07 | Nirmal Mulye | processo para a preparação de compimidos de liberação prolongada |
HUP0301537A3 (en) * | 2003-06-03 | 2005-07-28 | Egis Gyogyszergyar Nyilvanosan | Deramcyclane fumarate tablets and process for producing them |
US7713550B2 (en) | 2004-06-15 | 2010-05-11 | Andrx Corporation | Controlled release sodium valproate formulation |
WO2006025029A2 (en) * | 2004-08-31 | 2006-03-09 | Ranbaxy Laboratories Limited | Extended release composition of divalproex |
MX2007008985A (es) * | 2005-01-26 | 2007-12-06 | Elan Pharma Int Ltd | Composiciones de liberacion controlada que comprenden un agente anti-sicotico. |
US20070202164A1 (en) * | 2006-02-28 | 2007-08-30 | Hutchison Medipharma Enterprises Limited | Andrographis Extract Formulations |
CN102421428B (zh) * | 2009-05-12 | 2014-01-29 | 株式会社爱茉莉太平洋 | 用于防止脱发或促进毛发生长的组合物 |
WO2012121862A2 (en) * | 2011-02-17 | 2012-09-13 | University Of Florida Research Foundation | Valproic acid derivative compounds |
CN102138911B (zh) * | 2011-03-28 | 2012-12-12 | 孙卫东 | 一种双丙戊酸钠缓释片及其制备方法 |
CN102895201B (zh) * | 2011-07-26 | 2014-09-10 | 北大方正集团有限公司 | 丙戊酸半钠片剂及其制备方法 |
EP2919903B1 (en) | 2012-11-14 | 2020-07-22 | W.R. Grace & CO. - CONN. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
CN105012264B (zh) * | 2014-04-16 | 2019-11-29 | 四川科瑞德制药股份有限公司 | 丙戊酸钠缓释片及其制备工艺和用途 |
CN106389368B (zh) * | 2015-07-29 | 2021-11-12 | 四川科瑞德制药股份有限公司 | 一种丙戊酸钠缓释制剂及其制备工艺和用途 |
CN105456218A (zh) * | 2015-12-07 | 2016-04-06 | 黑龙江省智诚医药科技有限公司 | 一种丙戊酸镁缓释片及其制备方法 |
CN107028907B (zh) * | 2016-02-04 | 2021-05-14 | 成都康弘药业集团股份有限公司 | 一种双丙戊酸钠缓释片 |
CN114681419A (zh) * | 2020-12-28 | 2022-07-01 | 湖南省湘中制药有限公司 | 一种丙戊酰胺缓释片的组合物及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5169642A (en) * | 1988-06-24 | 1992-12-08 | Abbott Laboratories | Sustained-release drug dosage units |
US5009897A (en) * | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
FR2643556B1 (fr) * | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
IL96311A (en) * | 1989-12-01 | 1995-05-26 | Abbott Lab | Medications with delayed release |
US5075114A (en) * | 1990-05-23 | 1991-12-24 | Mcneil-Ppc, Inc. | Taste masking and sustained release coatings for pharmaceuticals |
TW224049B (es) * | 1991-12-31 | 1994-05-21 | Sunkyong Ind Ltd | |
TW222585B (es) * | 1992-09-11 | 1994-04-21 | Hoechst Ag | |
JP3552285B2 (ja) * | 1993-08-03 | 2004-08-11 | 三菱化学株式会社 | 経口コレステロール低下剤 |
GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
CA2216215A1 (en) * | 1997-04-05 | 1998-10-05 | Isa Odidi | Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity |
-
1999
- 1999-12-09 CZ CZ20012201A patent/CZ20012201A3/cs unknown
- 1999-12-09 PL PL99356899A patent/PL356899A1/xx not_active Application Discontinuation
- 1999-12-09 PT PT99968104T patent/PT1140034E/pt unknown
- 1999-12-09 IL IL14340799A patent/IL143407A0/xx unknown
- 1999-12-09 AT AT99968104T patent/ATE254907T1/de active
- 1999-12-09 HU HU0105463A patent/HUP0105463A3/hu unknown
- 1999-12-09 BR BR9916361-6A patent/BR9916361A/pt not_active Application Discontinuation
- 1999-12-09 SK SK825-2001A patent/SK8252001A3/sk unknown
- 1999-12-09 EP EP99968104A patent/EP1140034B1/en not_active Expired - Lifetime
- 1999-12-09 KR KR1020017007649A patent/KR20010101295A/ko not_active Application Discontinuation
- 1999-12-09 DE DE69913197T patent/DE69913197T2/de not_active Expired - Lifetime
- 1999-12-09 AU AU24789/00A patent/AU2478900A/en not_active Abandoned
- 1999-12-09 SI SI9920100A patent/SI20624A/sl not_active IP Right Cessation
- 1999-12-09 ES ES99968104T patent/ES2212667T3/es not_active Expired - Lifetime
- 1999-12-09 CN CN99814629A patent/CN1335769A/zh active Pending
- 1999-12-09 WO PCT/US1999/029204 patent/WO2000037055A1/en not_active Application Discontinuation
- 1999-12-09 JP JP2000589166A patent/JP2003513882A/ja active Pending
- 1999-12-09 CA CA002330480A patent/CA2330480C/en not_active Expired - Fee Related
- 1999-12-09 DK DK99968104T patent/DK1140034T3/da active
- 1999-12-15 CO CO99078240A patent/CO5160287A1/es unknown
- 1999-12-17 AR ARP990106552A patent/AR021443A1/es not_active Application Discontinuation
- 1999-12-18 TW TW088122338A patent/TW585788B/zh not_active IP Right Cessation
-
2001
- 2001-06-15 NO NO20012986A patent/NO20012986L/no not_active Application Discontinuation
- 2001-07-03 BG BG105665A patent/BG105665A/bg unknown
-
2002
- 2002-03-28 HK HK02102407.1A patent/HK1043043B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1140034E (pt) | 2004-03-31 |
SI20624A (sl) | 2002-02-28 |
CN1335769A (zh) | 2002-02-13 |
EP1140034B1 (en) | 2003-11-26 |
BR9916361A (pt) | 2002-11-05 |
CO5160287A1 (es) | 2002-05-30 |
DK1140034T3 (da) | 2004-03-08 |
HK1043043B (zh) | 2004-09-10 |
NO20012986D0 (no) | 2001-06-15 |
TW585788B (en) | 2004-05-01 |
BG105665A (bg) | 2002-03-29 |
KR20010101295A (ko) | 2001-11-14 |
DE69913197D1 (de) | 2004-01-08 |
IL143407A0 (en) | 2002-04-21 |
AU2478900A (en) | 2000-07-12 |
HK1043043A1 (en) | 2002-09-06 |
HUP0105463A3 (en) | 2003-03-28 |
ATE254907T1 (de) | 2003-12-15 |
PL356899A1 (en) | 2004-07-12 |
AR021443A1 (es) | 2002-07-17 |
EP1140034A1 (en) | 2001-10-10 |
ES2212667T3 (es) | 2004-07-16 |
WO2000037055A1 (en) | 2000-06-29 |
SK8252001A3 (en) | 2001-12-03 |
HUP0105463A2 (hu) | 2002-05-29 |
JP2003513882A (ja) | 2003-04-15 |
DE69913197T2 (de) | 2004-09-02 |
CA2330480C (en) | 2002-05-21 |
CA2330480A1 (en) | 2000-06-29 |
CZ20012201A3 (cs) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20012986L (no) | Kontrollert frigivende formulering av natrium divalproex | |
NO994946L (no) | Formuleringer med forlenget frigivelse av erytromycinderivater | |
AR026045A1 (es) | Formulaciones de liberacion prolongada de derivados de eritromocina | |
ID29021A (id) | Komposisi galantamina pelepasan terkontrol | |
PT1066027E (pt) | Composicao farmaceutica de topiramato | |
EE03426B1 (et) | Risperidooni vesilahuselised ravimvormid | |
PT954292E (pt) | Formulacoes farmaceuticas de libertacao retardada de farmaco | |
PT1109558E (pt) | Formulacoes de ranolazina de libertacao controlada | |
HUP0102128A3 (en) | Mediciaments containing benzimidazole derivatives as modulators of ige | |
LU90115B1 (fr) | Formulation orale de 2-méthyl-thiéno-benzodiazépine | |
HUP0103707A3 (en) | Formulation of stable oxalyplatinum solution | |
PT1109449E (pt) | Formulacoes de microcapsulas | |
AR027907A1 (es) | Composicion de liberacion controlada | |
NO20002126D0 (no) | Formulering med forlenget frigjøring | |
NO981166D0 (no) | Fremstilling av askorbylmonofosfater | |
ID27281A (id) | Sediaan bahan farmasi yang mengandung levotiroksin natrium | |
NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
ID25524A (id) | Komposisi pasta natrium sianida | |
NO20016030D0 (no) | Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin | |
SE9802197D0 (sv) | Formulations of busulphan | |
AU2002239259A1 (en) | Controlled release formulation of divalproex sodium | |
ID19295A (id) | Pelepasan formulasi yang diatur untuk obat-obatan yang kemampuan larutnya rendah | |
FR2763940B1 (fr) | Preparation de trifluoromethoxy-2-aniline | |
BR1100811A (pt) | Derivados de 1-metil-carbapenema | |
DE69814092D1 (de) | Wassermischbare Arzneizusammensetzung von Nimesulide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |